Inoviem Scientific offers a range of services tailored to the needs of drug discovery, preclinical and clinical development. We help researchers better meet all the key requirements to validate an experiment, accelerate drug development or achieve clinical trial objectives.

the Mode of Action of your compound

The ultimate understanding of the Mode of Action (MoA) of your compound with a patient centric approach.

Identify and validate drug-target engagement

Our robust empirical approach enables you to validate targets in a study model, identify secondary targets and validate a target engagement in a targeted organism.

Lead compound optimization

With greater emphasis on translational pharmacology, any number of compounds can be profiled, and we can identify within four weeks of study which one of these offers the best ‘druggability’ to move forward into development.

Patient stratification and biomarkers

Inoviem identifies the patient subset that will best respond to the compound by challenging patient material with drug in development.

Idendication prioritization

Should your promising compound fail in its primary indication, we can fast-track you to identifying a more efficient indication.

Identify biomarkers and clinical pharmacology

Inoviem’s translational pharmacology approaches empower your ability to identify promising biomarkers and advance clinical developments.


Inoviem Scientific provides Surface Plasmon Resonance (SPR) services to analyze the interactions of two biomolecules with respect to binding kinetics and affinity as well as binding specificity

Need Help